THE CLINICAL GENETICS SOCIETY
To advance and promote the science, education and practice of clinical genetics by workers who have the common interest to understand, prevent, cure and allieviate conditions with a genetic aetiology.
Financial health, per its FY2024 accounts
The accounts state that the charity held unrestricted cash funds of £81,511 at the end of the period. The trustees declared a policy of maintaining a working reserve of over £60,000 to protect the society's interests. No material uncertainties or risks to continuing operations were disclosed.
What the accounts disclose
“We currently have a bank balance in excess of £90,000 and feel that we need a working reserve of over £60,000 to protect the interests of the society.”
“We currently have a bank balance in excess of £90,000 and feel that we need a working reserve of over £60,000 to protect the interests of the society.”
Trustees
- Dr Emma Wakeling
- Dr Ian Harold Ellis
- Dr Meena Balasubramanium
- Dr Mohnish Suri
- Professor Diana Baralle
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £81k | £98k |
| 31/12/2023 | £56k | £23k |
| 31/12/2022 | £11k | £23k |
| 31/12/2021 | £18k | £2k |
| 31/12/2020 | £56k | £63k |
Common questions
Is THE CLINICAL GENETICS SOCIETY financially healthy?
Per its FY2024 accounts: The accounts state that the charity held unrestricted cash funds of £81,511 at the end of the period. The trustees declared a policy of maintaining a working reserve of over £60,000 to protect the society's interests. No material uncertainties or risks to continuing operations were disclosed. Its FY2024 accounts were independently examined.